Clinical trial
Interaction Between Omeprazole and Gliclazide in CYP2C19 Normal/ Ultrarapid Metabolisers
NCT04198948 is registered in ClinicalTrials.gov with University of Sarajevo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Interaction Between Omeprazole and Gliclazide in CYP2C19 Normal/ Ultrarapid Metabolisers
- Lead sponsor
- University of Sarajevo
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- March 4, 2019
- Completion date
- August 5, 2019
- Enrollment
- 15 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.